The application of AS-IV to the DKD rat model can be usefully applied to improve renal function and lesions, including tubulointerstitial inflammation and apoptosis of renal tubular epithelial cells, and inhibit the expression of CD36 and NLRP3. Here, NLRP3 is linked to diabetic kidney disease.